CAGR 6.9% Growth Predicted in Ligation Devices Market by 2024 with Top Leading Players and Technology

 Global Ligation Devices Market Report: By Product (Handheld Instruments, Accessories), Procedure (Minimally Invasive Surgery, Open Surgery), and Application (Gastrointestinal and Abdominal, Gynecological, Urological Applications)—Global Forecast till 2024

Market research future will be publishing a Half cooked research report on “Global ligation devices industry trends” that contains the information from 2019 to 2024. Ligation Devices Market is expected to grow at a CAGR 6.7% during the forecast period of 2019 to 2024.

Request Free Sample @ https://www.marketresearchfuture.com/sample_request/7794 

Market Research Future (MRFR) recognizes the following companies as the key players in the global Ligation Devices Market that includes Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc.

Key Players

Some of the key players in the global ligation devices market are Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc., and others.

Market Highlights
Ligation devices are used during surgeries for closing incisions or to join separated organs/tissue parts. Favorable reimbursement policies, rising healthcare expenditure, an increasing number of surgeries, and growing research and development expenditures are the factors driving the market growth. According to the Centers for Disease Control and Prevention in 2017, Coronary heart disease (CHD) was estimated to be the most common type of heart disease within the US and was projected to cause 370,000 per year. However, the high cost of surgery and related side effects are estimated to restraint the market growth.

Segmentation
The global ligation devices market is segmented based on product, procedure, application, end user, and region.

On the basis of product, the market is segmented into handheld instruments and accessories. Based on procedure, the market is segmented into minimally invasive surgery and open surgery. The application segment is segmented into gastrointestinal and abdominal applications, cardiovascular applications, gynecological applications, urological applications, and others. Based on the end user, the market is segmented into hospitals & clinics, ambulatory surgical center, and others.

Regional Analysis

The Americas dominated the global ligation devices market in 2018. Factors such as increasing healthcare expenditure and the rising incidence of chronic diseases are the major drivers within the region.

In 2018, it was estimated that Europe stood second in the global ligation devices market owing to increasing awareness, government support, development of technologically advanced medical products, and a growing number of surgeries. Moreover, the presence of developed economies (Germany, France, UK) boosts the market growth.

Asia-Pacific was the fastest growing region for the global ligation devices market in 2018. Factors such as increasing healthcare infrastructure, favorable government policies, an increasing number of surgeries and rising medical tourism drive the market growth within the region. According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector was estimated to be one of the fastest growing industries and is estimated to reach USD 280 billion by 2020 with a CAGR of 22.87% from 2015.

On the other hand, the Middle East and Africa held the least share in the global ligation devices market. Factors such as the presence of poor economies and low per capita income, especially within the African region make the market to lag within the region.

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/ligation-devices-market-7794

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

size share global Covid19 Impact on Lab-on-a-Chip Market size research key companies review forecast to 2023

 Lab-on-a-Chip Device Market Information: Product (Instruments, Reagents & Consumables), Technology (Microarrays, Microfluidics), Application (Point of Care Diagnostics), and End-User (Biotechnology and Pharmaceutical Companies) – Global Forecast Till 2023

Market Highlights

The Lab-on-a-Chip Market size is forecasted to exhibit robust growth registering a CAGR of 10% during the forecast period. The global Lab-on-a-Chip Market size is majorly driven by increasing application of lab on chip devices in the medical field in the diagnosis of various infectious diseases which eases sample handling and yields efficient results in a snap of time. Similarly, the use of lab-on-a-chip devices in research purposes is gaining traction due to easy portability, automated biochemical assays, and huge sample handling provision. Moreover, rising demand for miniature devices, advancing fabrication technology, research on biosensors and biomarkers, and economic feasibility of lab-on-a-chip devices are expected to spur the market growth. However, initial higher purchasing rate, as well as lack of awareness about the use of lab-on-a-chip devices in middle-income countries, are major restraints to the market growth.

Read More Here!! https://www.medgadget.com/2018/07/lab-on-a-chip-device-market-10-cagr-exhibit-robust-growth-with-top-10-players-by-2023-exclusively-available-at-marketresearchfuture-com.html

Regional Analysis

Americas is the market leader and has an attractive market for lab on chip devices owing to increasing advances in molecular biology and genetic engineering techniques as well as increasing prevalence of infectious diseases.  Additionally, factors such as increasing number of genomic and proteomics research labs government initiatives and funding for research, development of advanced medical treatment options, and rising demand for portable devices are likely to enhance the growth of Lab-on-a-Chip Market size in the American region. For instance, According to stats presented in the Centers for Disease Control and Prevention report in the year 2017, around 49.9% of the children between the ages of 6 months to 17 years in the U.S. received an influenza vaccine. Due to the alarming rate of chronic as well as infectious diseases, use of lab-on-a-chip devices is accelerated due to its precision in diagnosis and multiple samples handling feature.

Europe is the second largest market and holds a healthy share in the global Lab-on-a-Chip Market size due to major driving factors such as the flourishing medical device market, favorable government initiatives to promote life-science and clinical research, rising average per capita income of individuals. For instance, the European Commission stated that the R&D spending by the pharmaceuticals and biotechnology sectors grew by 8.7% in 2014. This investment in R&D along with the ongoing legislative reforms is expected to have a positive impact on the Lab-on-a-Chip Market size.

The Asia-Pacific is expected to be the fastest growing market owing to the faster adaptation of healthcare technology, increasing patient pool of chronic and infectious diseases, government initiatives of healthcare reform, increasing number of CROs and research projects on environmental issues. Furthermore, key medical device players have set up their regional headquarters and manufacturing plants in Singapore, China, Japan,  and Australia thus, boosting the growth of Lab-on-a-Chip Market size.

The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates is the largest market share owing to the development of the healthcare industry and sound economic status of inhabitants. However, this area has the possibility to grow during the forecast period as due to increasing outbreak of new opportunistic pathogen associated diseases like Ebola, Zika Virus, and Hepatitis B which has attracted key players to set up their R&D centers in this region.

Access Report @ https://www.marketresearchfuture.com/reports/lab-on-a-chip-device-market-6215

Industry Trends:

A Scotland based company uFraction8 Ltd. has recently come up with a microfluidic-based filtration system which is an essential part in remodeling the LoCs. Other innovations are also startling and can revolutionize the segment by taking the practice some light years ahead. Researchers from the Brigham Young University have now developed a technology that can 3D print LoC.

Segmentation:

The global LoC device market can be segmented by product, technology, application, and end-user. 

Product-wise, the market includes instruments, reagents & consumables, software, and others. Researchers from Biozentrum of the University of Basel and Max Planck Institute in Dresden have set up a LoC along with automatic analysis software that can study single cell responses. 

Based on application, the market comprises genomics, proteomics, the point of care diagnostics, drug discovery and others. LoC has revamped genomic field of study by taking down the time of detection by a considerable margin. Researchers from Griffith University’s Queensland Micro and Nanotechnology Centre have discovered new ways to screen drugs by using LoC that would reduce the drug testing time considerably.

By end-user, the market consists, hospitals and clinics, biotechnology and pharmaceutical companies, forensic laboratories, diagnostics centers, and academic & research institutes.

 

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:                                    

Akash Anand                                                                        

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Global Research on Cruciate Ligament Diagnosis & treatment Market

 Cruciate Ligament Diagnosis & treatment Market Research Report: Injury Type (Grade I, II, III), Product (Cement Implants, Cement-Less Implants), Indication (Osteoarthritis, RA), Treatment (Surgery), End-User (Hospitals, ASCs) – Global Forecast Till 2023

Market Highlights

The cruciate ligament treatment includes numerous surgical techniques that involve reconstruction and replacement of the knee and related ligaments. The upsurge in obese population is considered as a chief factor emphasizing the growth of this market. Obesity in the aging population has been reported to directly increase the risk of degenerative bone disorders, such as osteoporosis and osteoarthritis, additionally resulting in target injury and fracture owing to the extra pressure exerted on joints. Later, increasing number of people who have osteoporosis is expected to generate demand for the market.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6080

However, the lack of availability of skilled professionals and the high cost of treatment procedures may hinder the growth of the market during the forecast period.

Many prominent players in the market have incorporated into acquisitions, mergers, and continuous launches of quality systems to hold the market position. The firms are focusing on mergers and acquisitions to enhance their product portfolio. For instance, the acquisition of Cayenne Medical by Zimmer Biomet was involved in reconstruction solutions and advanced soft tissue repair for knee, shoulder, and extremities. Besides, companies are involving into geographic expansions to cater to the untargeted population for tissue repair and surgeries.

Regional Analysis

The global cruciate ligament diagnosis and treatment market consists of four regions, namely, Americas, Europe, Asia Pacific, and the Middle East and Africa.

The American region holds the major share of the global cruciate ligament diagnosis and treatment market, owing to the existing well-established healthcare system, increasing prevalence of degenerative bone disorder cases, and technological advancements. Sports such as soccer, football, and skiing have been reported to be high-risk sports that can cause injury to the ACL when compared to other sports activities. For instance, due to increasing occurrences of ACL injuries, nearly 100,000 ACL reconstructions are performed each year as per a report published by PubMed.

Europe holds the second position in the global cruciate ligament diagnosis and treatment market. It is expected that the government support towards research and development expenditure and rising prevalence of chronic bone diseases are likely to drive the European cruciate ligament diagnosis and treatment market.

The Asia Pacific cruciate ligament diagnosis and treatment market consist of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia Pacific. Japan is the largest market for cruciate ligament diagnosis and treatment due to an increase in the prevalence of cancer and demand for cruciate ligament diagnosis and treatment techniques. In China, factors responsible for the market growth are rising geriatric population with osteoporosis diseases and availability of low-cost diagnostic and treatment options.  

The Middle East and Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.

Access Report @ https://www.marketresearchfuture.com/reports/cruciate-ligament-diagnosis-treatment-6080

Segmentation

The global cruciate ligament diagnosis and treatment market is segmented on the basis of type, injury type, product, diagnosis, treatment, and end-user.

Based on type, the global cruciate ligament diagnosis and treatment market is classified as Posterior Cruciate Ligament (PCL) and Anterior Cruciate Ligament (ACL).

The segments for injury type for the global cruciate ligament diagnosis and treatment market are classified as grade I, grade II, and grade III.

On the basis of product, the global cruciate ligament diagnosis and treatment market is classified as cemented implants, cement-less implants, partial implants, and revision implants.

Based on indication, the global cruciate ligament diagnosis and treatment market is classified as osteoarthritis, rheumatoid arthritis, trauma, and others.

The diagnosis segment for the global cruciate ligament diagnosis and treatment market is classified as imaging and others. The imaging segment is further classified as abdominal x-ray, Magnetic Resonance Imaging (MRI), ultrasound, laparoscopy, angiography, and others.

Based on treatment, the global cruciate ligament diagnosis and treatment market is classified as surgery, therapies, devices, and others. Surgery can be further sub-divided into arthroscopy, Anterior Cruciate Ligament (ACL) reconstruction, and others. The therapies include rehabilitation and physical therapies. The devices include elastic bandages and others.

On the basis of end-user, the global cruciate ligament diagnosis and treatment market is classified as hospitals, orthopedic clinics, Ambulatory Surgical Center (ASC), and others.

Global Cruciate Ligament Diagnosis & Treatment Key Players

Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Zimmer Biomet (U.S.), DePuy Synthes, Inc. (U.S.), CONMED Corporation (U.S.), Smith & Nephew plc. (U.S.), DJO Global Inc. (U.S.), Breg, Inc. (U.S.), Bauerfeind AG (Germany), Össur hf. (Iceland), DeRoyal Industries, Inc. (U.S.), BSN Medical GmbH (Germany), 3M Company (U.S.), Otto Bock Healthcare GmbH (Germany), THUASNE SA (France), medi GmbH & Co. KG (Germany), DeRoyal Industries Inc. (U.S.), Corin Group (UK), United Orthopedic Corporation (Taiwan), Exactech Inc. (U.S.), Japan Medical Dynamic Marketing (Japan), Tornier Inc. (U.S.), and others are some prominent players in this market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 

Global Covid19 Impact on Body Contouring Devices and Procedures Market 2019 Assessment On Competition 2023

 Market Highlights:

The Global Body Contouring Devices and Procedures Market.  held a market value of USD 2,103 million in 2017 and is projected to grow at a CAGR of 6.6% over the forecast period.Body contouring is a altering the body part by improving the appearance. It involves the removal or transfer of fat to the body.  

You Can Read Also Here!! https://www.medgadget.com/2019/09/body-contouring-device-market-analysis-by-global-industry-size-share-trends-growth-report-competitive-landscape-and-regional-forecast-to-2023.html 

Due to increasing prevalence of obesity across the globe many of the companies are in the race to introduce better treatment for obesity. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market.

Additionally, the growing research and development expenditure by the government as well as private sector is likely to contribute to the market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, the high cost of urgery with advanced technologies may hamper the market growth during the assessment period.

Regional Analysis:

On regional basis, the Americas is anticipated to dominate the global body contouring devices and procedures market size owing to the growing R&D budgets by both government as well as commercial pharmaceutical and biotechnological companies and increasing adoption of advanced technologies in the region.  Europe is expected to hold the second largest position in the global body contouring devices and procedures market owing to the presence of strong academic & research base and availability of funding for research in the European countries. Asia Pacific has served an opportunity for developing body contouring market in this region due to increasing demand for the better treatment and devices and increasing prevalence of disease like diabetes and obesity. The Middle East & Africa has the least share of the global body contouring devices and procedures market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the healthcare sector.

Segmentation:

The global body contouring devices and procedures market has been segmented into type, procedure, and end user. By type, the market has been segmented into non-invasive & minimally invasive devices and invasive devices. The non-invasive & minimally invasive devices segment is estimated to hold major market share in the global body contouring devices and procedures market due to the huge investments by major market players for the development of advanced technologies and equipment.

Based on procedure, the market has been segmented into non-surgical skin resurfacing, non-surgical skin tightening, cellulite treatment, liposuction, and others. The market, by end user, has been segmented into hospitals & clinics, research institutes & Organization, and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/body-contouring-devices-and-procedures-market-6935 

Key Players:

Some of the prominent players in the global body contouring devices and procedures market are Cynosure, Inc., Alma Lasers, Alleragan, Syneron Medical Ltd, Bausch Health Companies, Inc, Lumenis, Merz Pharma GmbH & Co., Palomar Medical Technologies Inc., Sound Surgical Technologies LLC., Zeltiq Aesthetics, Chromogenex Technologies LTD, UltraShape Ltd, Fotona, Misonix Inc., Medicis Pharmaceutical Corporation, Sientra Inc., Invasix Ltd, Erchonia Inc, Lutronic.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Biomarker Technologies Market Perceive A Distinctive Growth at a CAGR 9% By 2023 | MRFR

 Biomarker Technologies Market Information: By Product (Consumables, Instruments), by Profiling Technology (PCR, Imaging Technology, NGS), by Disease Application (Cancer, Infectious Disease), Research Area (Genomics, Proteomics) – Global Forecast Till 2023

Biomarker Technologies Market Insights

Market Research Future has announced its new research report on the global biomarker technologies stating that the market is probable to rise at a CAGR of 9% till the year 2023. The reports also mention that the market is all set to gain a valuation of USD 78 Billion in the years to come, which is a sign of positive impact of the market on global level. The report takes in account the parts such as regional, type, and application segmentation of the global biomarker technologies, which portrays the market status among all these categories.

You Can Also Read Here !! https://www.medgadget.com/2020/07/biomarker-technologies-market-2020-global-trends-industry-insights-technology-innovation-growth-factors-demand-by-2023.html

The biomarker is defined as a measurable indicator of some biological state or condition. The term is also referred as a solid substance that detects and indicates the presence of a living organism. In medicine, a biomarker traces to examine proper functioning of any organ, whereas in cell biology, a biomarker is used for the detection of cellular defects and isolation of a cell type. And in genetics, a biomarker is a stretch of DNA sequence that can be used to create genetic maps for any organism. Even for diagnosis and clinical decision making, biomarkers are referred especially for cancer, diabetes, cardiovascular, and neurological diseases. These features of biomarkers are predominantly encouraging the global biomarker technologies to expand exponentially in the years to come.

Global Biomarker Technologies: Drivers & Trends

The global biomarker technologies market is expanding globally under various factors such as   increased incidences of diseases—cancer, diabetes, cardiovascular, and neurological diseases, advances in medical technologies, governmental initiatives supporting research in biomarker technologies, and growing use of biomarkers to increase the accuracy of disease diagnosis.

Currently, the most important applications of biomarkers are in discovery and development of drug. Here, the role of biomarkers in various therapeutic areas particularly cancer, cardiovascular diseases and disorders of the central nervous system, is described in well version. Biomarkers, thus, facilitates the combination of therapeutics with diagnostics and plays an important role in the development of personalized medicine. These factors are also influencing the global biomarker technologies market to expand tremendously during the forecast period.

Apart from this, the growth of the global biomarker technologies market is mainly driven by more factors such as increasing healthcare expenditure and increasing research & developing funding. It has been observed, that the swelling utility of biomarkers in diagnostic process and new initiatives for biomarker research, all are aiding for the growth of the market. Nevertheless, the requirement of high capital investments for the discovery, development, and validation of biomarkers are somehow restraining the growth of the biomarker technologies market.

Also, on the flip side, factor of high cost of biomarkers are restricting the growth of the biomarker technologies market.

Market Segmentation

According to MRFR, the global biomarker technologies market has been segmented based on product type, profiling technology, disease application, and research areas.

By the product type, the market is segmented into consumables, instruments, services, and software/informatics.

By profiling technology type, the market is segmented into immunoassay, PCR, imaging technology, mass spectrometry, NGS, chromatography, cytogenetics, and other technologies.

By immunoassay, the market is again segmented into ELISA, western blot, and protein microarray.

By disease application, the market is categorized as cancer, infectious disease, autoimmune diseases, neurological, cardiovascular disorders, and other disorders.

By research areas, the market is segmented into Genomics, Proteomics, Metabolomics, and other research areas. Metabolomics is further segmented into lipidomic and others.

Regional Outlook

On a geographical note, the global biomarker technologies market has covered main regions of Americas, Europe, Asia Pacific, and the Middle East and Africa.

Among these, Americas is going to account for the largest share of the biomarker technologies market owing to the increasing prevalence of cancer, cardiovascular diseases, neurological as well as autoimmune diseases, and rising geriatric population. These factors are likely to enhance the growth of the biomarker technologies market. Also, the increasing patient pool is likely to enhance the market growth during the forecast period. Moreover, the increasing government initiatives and funding for research, development in advanced medical treatment options, and availability of favorable reimbursement policies are likely to propel the growth of the biomarker technologies market in the American region.

While, Europe is the second market leader and holds a healthy share in the global biomarker technologies market and is expected to exhibit a sturdy growth rate during the forecast period owing to the availability of advanced treatment facilities and established healthcare infrastructure along with growing need for efficient and accurate diagnosis.

Whereas, Asia Pacific is expected to be the fastest emerging market owing to the increasing prevalence of chronic diseases is the major driver for the market growth. China and India are the first and second most affected countries with diabetes. The increasing number of diabetic patients can lead to the increasing patient number with cardiovascular diseases. Thus, these countries are expected to be the fastest growing regions due to the increasing patient pool, raising awareness about health, and availability of new treatment methods.

The Middle East and Africa is expected to show the least growth in the market due to some major factors such as lack of awareness and limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates is the largest market owing to the development of the healthcare industry and rising availability of specialty care centers. With the increasing number of epidemic diseases in this region, many key players are willing to set up their research and development centers to find a cure for these diseases. This will increase the usage of biomarkers and thus, a steady growth rate might be seen during the forecast period.

Market Players

MRFR has listed some of the most active market players contributing to the market to expand, they are: Abbott Laboratories

• Agilent Technologies
• Thermo Fisher Scientific
• Roche
• Waters Corporation
• Danaher Corporation
• Shimadzu Corporation
• Danaher Corporation
• Siemens Healthcare

Read Complete Report @ https://www.marketresearchfuture.com/reports/biomarker-technologies-market-6150

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Global Artificial Intelligence in Drug Discovery Market 2019-2025 | 40.8% CAGR Projection over the Next Five Years

The AI in drug discovery market is growing continually. Artificial intelligence technology has the potential to revolutionize the pharmaceutical sector and open whole new avenues for technology providers. Resultantly, the adoption of the AI technology to boost efficiency and throughput in clinician workflow is rising steadily. Moreover, the growing applications of AI technology in various drug discovery and development process escalate the market demand to furthered height. 

Download Sample Table of Content PDF of COVID-19/CoronaVirus Impact Analysis of AI in drug discovery market 2020 @https://www.marketresearchfuture.com/sample_request/9393 

According to Market Research Future (MRFR), the global AI in drug discovery market is poised to create a valuation of USD 2,015.1 MN by 2025, registering a massive 40.8% CAGR throughout the predicted years (2019 – 2025). Recent COVID 19 pandemic is projected to boost the size of the market. AI and machine learning integration in discovery and development applications are increasing to expedite drug development processes. 

Also, substantial investments made into AI business are projected to boost the market growth. AI integration minimizes the risk of adverse reactions during trials, reduces the drug

AI in Drug Discovery Market – Regional Analysis

North America dominates the global AI in drug discovery market. Market share attributes to the increasing prevalence of chronic diseases and high healthcare expenses. Moreover, the recent COVID 19 pandemic is estimated to increase the size of the regional market. Besides, factors such as the presence of growing numbers of big AI platform developers and a well-developed healthcare sector in the region allow rapid market growth. 

Increasing adoption of top AI platforms, including Google AI, Microsoft Azure, and TensorFlow by major pharma companies in drug discovery processes, boost the regional market growth. Moreover, increasing demand for Artificial Intelligence technologies from key pharmaceutical companies such as AbbVie, Genentech, Eli Lilly and Company, and Amgen, among others, drive the growth of the market. 

Europe stands second in the global AI in drug discovery market. Market growth is driven by the increasing R&D activities in the pharma sector and the high demand for AI solutions by drug development companies. Top pharma companies in the region form strategic partnerships with international AI service providers to expedite their drug discovery process, which, in turn, boosts the market growth. The UK, Germany, and France are the major growth contributors to the regional market. 

Additionally, substantial R&D investments and increasing government funding in the development of AI technology foster regional market growth. Furthermore, the recent COVID 19 epidemic is estimated to increase the size of the regional market. Besides, strategic deals between the UK government and industry players are expected to increase AI research investments. The European AI in the drug discovery market is projected to create a substantial revenue pocket. 

The Asia Pacific AI in drug discovery market is estimated to become the fastest-growing market. Factors such as the increasing demand for effective drug discovery solutions and rapidly growing pharmaceutical sectors in the region drive market growth. A number of start-ups in the region are working to integrate  Artificial Intelligence in Drug Discovery Market. It is predicted that the adoption of AI technologies in mainstream drug discovery protocols will take place in the future. With their increasing numbers of AI platform companies, countries like India and China contribute significantly to the regional market growth.

discovery timeframe, and, most importantly, reduces drug development costs. Machine learning and other AI tools have a vast potential to make the discovery of new pharmaceuticals faster, cheaper, and more productively. As a result, major pharma companies are increasingly using AI technology for drug discovery. 

Moreover, rising numbers of start-ups operating in the AI spectrum drug discovery foster market growth. Simultaneously, increasing numbers of cross-industry partnerships formed to achieve improvements in drug development outcomes drive the growth of the market. On the other hand, high costs associated with AI integration are a major factor estimated to hamper the market growth. Also, the lack of adequate infrastructure in low economic countries obstructs the growth of the market. 

 

AI in Drug Discovery Market – Segments

The report is segmented into seven dynamics; 

By Product Type       : Services and Software. 

By Molecule Type: Large and Small Molecules.

By Technology         : Machine Learning, Deep Learning, and others. 

By Indication             : Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and others. 

By Application          : Target Identification, Candidate Screening, De novo Drug Designing, Drug Optimization & Repurposing, Preclinical Testing, and others. 

By End-User : Pharmaceutical & Biotechnology Companies, Research Centers and Academic & Government Institutes, Contract Research Organizations, and others. 

By Regions                : Americas, Europe, Asia Pacific, and Rest-of-the-World. 

AI in Drug Discovery Market   - Competitive Analysis 

The global AI in drug discovery market appears fiercely competitive & fragmented due to the presence of numerous well-established players. To gain a larger competitive advantage in the market, these players incorporate strategic initiatives such as mergers & acquisitions, collaborations, technology launch, and expansion. Also, AI drug discovery companies make substantial investments to R&D and drive clinical studies.  

Read More !!https://www.medgadget.com/2020/05/covid-19-economic-impact-on-ai-in-drug-discovery-market-2020-technology-trends-industry-demand-growth-top-leaders-size-estimation-business-opportunities-challenges-and-outlook-to-2025.html

Major Players: 

Players leading the global AI in drug discovery market include Microsoft Corporation, IBM Corporation, Alphabet Inc., Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI, Exscientia, Cyclica, Bioage, Numerate, Numedii, Inc., Envisagenics, Twoxar, Incorporated, Owkin, Inc., Xtalpi, Inc., Verge Genomics, and Berg LLC, among others. 

Innovation/Industry/Related News:

June 01, 2020 ---- Syntekabio Inc. (South Korea), a bioinformatics venture firm and AI drug Daevelopment Company, announced the identification of a respiratory disease drug as a potential COVID19 therapeutics. The crystal structure of SARS-CoV-2’s 3CL protease (Mpro) is the main viral protease that plays a crucial role in viral gene expression and proliferation of the SARS-CoV-2 virus. As soon as this structural information became available, Syntekabio commenced AI screening using its proprietary AI platform DeepMatcherTM and supercomputer. The company screened 3,000 approved drugs and identified potential COVID-19 therapeutics.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:        

Akash Anand             

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com 

 

Aromatherapy Market 2020: Applications, Types and Growing Trends in Market, Gross Margin and Market Share 2023

 Aromatherapy Market analysis

 Aromatherapy is an alternative form of medicine which relies on scented oils and other essential compounds for improving the well-being of individuals. It can be used in conjunction with other complementary treatments of acupuncture or massage for management of chronic diseases or other medical symptoms. The global aromatherapy market report compiled by Market Research Future (MRFR) contains drivers, trends, developments, and challenges new entrants and existing players can face in the period of 2017 to 2023.

you Can Also Read here@https://www.medgadget.com/2020/08/aromatherapy-market-regional-insights-2020-global-trends-robust-expansion-by-top-key-manufactures-demand-growth-factors-research-report-segmentation-and-forecast.html

Market Overview

As per MRFR, the global Aromatherapy Market Analysis is poised to display a CAGR of 6.18% from 2017 to 2023 (forecast period). It can touch a value of USD 4.3 billion by 2023. Benefits of the treatment after inhalation of the aroma can induce relaxation is likely to bode well for the market. A prime example includes the diffusion of eucalyptus oil can assist in digestion of foods.

Changes in lifestyles of consumers and a large number of people opting for the complementary treatment are other major drivers of the market. Clinical trials advocating the advantages of aromatherapy for the treatment of disorders can influence the market considerably. According to Cancer.gov, 58 patients showed a decrease in depression and anxiety after completion of aromatherapy sessions. Availability of various oils at lifestyle stores and online channels can fuel the global aromatherapy market growth till 2023.

But lack of proper regulations and allergic reaction of the oil to customers are factors which can prevent market growth.

Competition Outlook

Muji, Nu Skin, Tree of Life, Neal's Yard Remedies, NOW Foods, Young Living, Air Aroma, doTERRA, and Zija International are notable industry participants of the global aromatherapy market. Launch of new products and associated stationery are being launched by players for promoting the alternative form of treatment.

 Segmentation

The global aromatherapy market is segmented by product, application, and therapeutic application.

By product, it is segmented into essential oils, carrier oils & blended oils, equipment, and others. Essential oils are further segmented into herbaceous/camphoraceous, green/vegetative, spicy, citrus, floral, and others. Ultrasonic diffuser, heat diffuser, and nebulizer diffuser are other segments subsumed within the equipment segment.

By application, it is segmented into aerial diffusion, inhalation, and tropical.

By therapeutic application, it is segmented into skin and hair care, relaxation and sleep, pain management, and others.

Regional Analysis

Asia Pacific (APAC), North America, Europe, and the Middle East & Africa (MEA) are the regions discussed with respect to the market report.

North America is estimated to be one of the profitable regions for the global aromatherapy market till 2023 due to consumers opting for the treatment in the U.S. The large population and their high expendable income levels are major growth drivers of the region.

Europe is the second-largest region with France and Italy proving to be the revenue generators. Pursuance of healthy lifestyles as well as renewed interest among the people residing in the region are prime factors driving market growth. The inclusion of essential oils by popular cosmetic brands can boost the global aromatherapy market demand.

The APAC region can display a robust CAGR during the forecast period driven by consumer demand in China and India. Rising number of accidents combined with the use of oils for treating burns and scars as natural remedies can bode well for the market. Furthermore, old traditions and rituals in addition to the large number of tourists visiting for experiences can bode well for the region.

Lastly, the MEA region can contribute to the market due to the regions of Saudi Arabia and UAE. Efforts by respective governments for promoting tourism can be a viable factor for the expansion of the global aromatherapy market in the region.

Industry News

Aromafloria, the US based producer of bath and body products, has launched aromatherapy based products in its new product line of Cannafloria Essentials. It contains cannabis terpenes which gives the solutions a distinct aroma.

Read more @ https://www.marketresearchfuture.com/reports/aromatherapy-market-3241

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com